February 14, 2025
GermZAPP is an affordable hand hygiene system designed to educate, monitor, and encourage adherence in schools, nursing homes, and health care settings, effectively addressing gaps in infection control.
January 10, 2025
Barinthus Bio’s Phase 2b trial shows VTP-300’s potential to achieve functional cures for chronic hepatitis B, with promising HBsAg loss, safety, and durable immune responses.
December 12, 2024
Today's Infection Intel discusses updates from Johnson & Johnson MedTech, Merck and Ridgeback, MicroLumix, and Evinature. Read on to learn the latest.
December 05, 2024
Infection Control Today’s Infection Intel learns more about Stryker’s Oculan Lighting Platform and Hexaware Technologies’ Clinical Data Automation as a Solution (CDAaaS).
August 08, 2024
Jackie Otero, senior territory sales representative at Abatement Technologies, discusses the SHIELD WALL modular containment system by Abatement Technologies, highlighting its quick assembly, durability, noise reduction, and benefits in maintaining indoor air quality in health care settings.
June 27, 2024
TigerConnect's secure text-based platform, led by Will O'Connor, MD, reduces noise, minimizes wait times, and improves patient care through efficient clinical workflow coordination and nurse burnout alleviation.
June 12, 2024
Nature Communications published the results of a study on ARCT-154, CSL’s sa-mRNA COVID-19 vaccine. The study showed that it is well-tolerated, immunogenic, and effective against multiple strains.
May 21, 2024
A new medical device uses microneedles and a suction cup to simplify blood sampling. It aids needle-phobic patients and benefits low-income regions with cost-effective diagnostics.
May 17, 2024
Discover how SpaceWalker's innovative cooling solutions reduce carbon footprints and ensure pharmaceutical integrity, setting new standards in sustainable cold chain logistics.
May 02, 2024
Health care has an unmet need for the treatment of herpesviruses, hepatitis B, and hepatitis D, which would enhance patient outcomes. What should be done, and what challenges do companies that are trying to develop treatments face?